Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Check out our latest analysis for Royalty Pharma For anyone who wants to understand Royalty Pharma's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from US$349m worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Royalty Pharma doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. We'd posit that Royalty Pharma's statutory earnings aren't a clean r
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Looking For Yields: Comcast, Royalty Pharma And Regions Financial Are Consistent Moneymakers [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at TD Cowen to a "strong-buy" rating.MarketBeat
- Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company [Yahoo! Finance]Yahoo! Finance
- Lightning Round: M&T Bank is a buy, I like the banks, says Jim Cramer [CNBC]CNBC
- 3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- 12/31/24 - Form 8-K
- RPRX's page on the SEC website